Select country change
Shopping cart (0 , 0,00 ) Menu Search
Manufactured by BioVendor

Surfactant Protein D Human ELISA

  • Regulatory status:RUO
  • Type:Sandwich ELISA, Biotin-labelled antibody
  • Other names:SP-D
  • Species:Human
Please select your region to see available products and prices.
Cat. No. Size Price


RD194059101 96 wells (1 kit)
PubMed Product Details
Technical Data

Type

Sandwich ELISA, Biotin-labelled antibody

Applications

Serum, Plasma-EDTA, Plasma-Heparin, Plasma-Citrate, Bronchoalveolar lavage, Amniotic fluid

Sample Requirements

10 µl/well

Shipping

At ambient temperature. Upon receipt, store the product at the temperature recommended below.

Storage/Expiration

Store the complete kit at 2–8°C. Under these conditions, the kit is stable until the expiration date (see label on the box).

Calibration Curve

Calibration Range

1.56–100 ng/ml

Limit of Detection

0.01 ng/ml

Intra-assay (Within-Run)

n = 8; CV = 2.2%

Inter-assay (Run-to-Run)

n = 5; CV = 3.1%

Spiking Recovery

95,60%

Dilution Linearity

97,10%

Crossreactivity

  • bovine Yes
  • cat Non-detectable
  • dog Non-detectable
  • goat Non-detectable
  • hamster Non-detectable
  • horse Yes
  • mouse Non-detectable
  • pig Non-detectable
  • rabbit Non-detectable
  • rat Non-detectable
  • sheep Non-detectable
  • chicken Not tested
  • monkey Yes
  • human Yes
Summary

Features

  • European Union: for in vitro diagnostic use
  • Rest of the world: for research use only!
  • The total assay time is less than 5 hours
  • The kit measures total surfactant protein D in serum, plasma (EDTA, citrate, heparin), bronchoalveolar lavage fluid and amniotic fluid
  • Assay format is 96 wells
  • Quality Controls are human serum based. No animal sera are used
  • Standard is recombinant protein based
  • Components of the kit are provided ready to use, concentrated or lyophilized

Research topic

Immune Response, Infection and Inflammation, Pulmonary diseases

Summary

Human Surfactant Protein D (SP-D) is a member of the collageneous subfamily of
glycoproteins and calcium-dependent lectins (collectins).
SP-D is a homotrimeric protein consisting of three 43kDa units that are bonded at their Ntermini.
Most preparations of SP-D contain predominantly dodecamers (four trimeric subunits),
but also higher multimers have been observed. Each unit consists of at least four discrete
structural domains: a short N-terminal domain; a relatively long collagenous domain, a short
amphipathic connecting peptide, and a C-terminal, C- type lectin carbohydrate recognition
domain (CRD).

SP-D is synthesized and secreted by two types of non-ciliated epithelial cells in the peripheral
airway, alveolar type II cells and Clara cells. It is also expressed by various epithelial cells in
the gastrointestinal and genitourinary tracts and placenta.
In the lungs, SP-D participates in the innate response to inhaled microorganisms and organic
antigens. SP-D acts by aggregating bacteria and viruses, leukocyte function and stimulating an
allergenic response. SP-D binds to the surface glycoconjugates of various microorganisms (eg,
influenza virus, HIV, HSV, RSV, Mycoplasma pneumoniae) and the oligosaccharides
associated with the surface of numerous organic antigens and enhances their phagocytosis.
Studies have shown that SP-D binds to T cells, thus inhibiting their proliferation. SP-D also
binds with inflammatory ligands via protein-protein and protein-carbohydrate interactions that
are effective in reducing specific inflammation. In addition, SP-D binds to apoptotic cells and
stimulates their phagocytosis by macrophages governed by mechanisms dependent and CD91
calreticulin.

Given that SP-D together with SP-A affects the reactivity of immune cells, their presence in the
endometrium and placenta plays an important role in protection against bacteria and toxins
during pregnancy. Reduced levels of all components of pulmonary surfactant, including SP-D,
has been linked to premature birth.

Disturbance of pulmonary surfactant is in many cases the reason for collapse of the lungs and
is also associated with many pulmonary diseases. All types of chronic lung disease is
characterized by pathologically altered levels in lung tissue (fibrosis and emphysema). Studies
have shown that expression of SP-D is associated with many pulmonary diseases: cystic
fibrosis, acute interstitial pneumonia (ARDS), chronic obstructive pulmonary disease, asthma,
bronchopulmonary dysplasia, alveolar capillary dysplasia, alveolar proteinase and tuberculosis.
Clinical application and areas of investigation: Cystic fibrosis, Acute interstitial pneumonia (ARDS), Chronic obstructive pulmonary disease, Asthma, Bronchopulmonary dysplasia, Alveolar capillary dysplasia and alveolar proteinase, Immune response, infection and inflammation

Product References (72)

References

  • Alexis NE, Lay JC, Haczku A, Gong H, Linn W, Hazucha MJ, Harris B, Tal-Singer R, Peden DB. Fluticasone propionate protects against ozone-induced airwayinflammation and modified immune cell activation markers in healthy volunteers.Environ Health Perspect. 2008 Jun;116(6):799-805. doi: 10.1289/ehp.10981. PubMed PMID: 18560537; PubMed Central PMCID: PMC2430237. See more on PubMed
  • Anderson JT, Zeng M, Li Q, Stapley R, Moore DR 2nd, Chenna B, Fineberg N,Zmijewski J, Eltoum IE, Siegal GP, Gaggar A, Barnes S, Velu SE, Thannickal VJ,Abraham E, Patel RP, Lancaster JR Jr, Chaplin DD, Dransfield MT, Deshane JS.Elevated levels of NO are localized to distal airways in asthma. Free Radic Biol Med. 2011 Jun 1;50(11):1679-88. doi: 10.1016/j.freeradbiomed.2011.03.015. Epub2011 Mar 16. Erratum in: Free Radic Biol Med. 2013 May;58:45. PubMed PMID:21419218; PubMed Central PMCID: PMC3124865. See more on PubMed
  • Aul R, Armstrong J, Duvoix A, Lomas D, Hayes B, Miller BE, Jagger C, Singh D. Inhaled LPS challenges in smokers: a study of pulmonary and systemic effects. Br J Clin Pharmacol. 2012 Dec;74(6):1023-32. doi: 10.1111/j.1365-2125.2012.04287.x. PubMed PMID: 22469312; PubMed Central PMCID: PMC3522816. See more on PubMed
  • Ban WH, Kang HH, Kim IK, Ha JH, Joo H, Lee JM, Lim JU, Lee SH, Rhee CK.Clinical significance of nuclear factor erythroid 2-related factor 2 in patients with chronic obstructive pulmonary disease. Korean J Intern Med. 2018Jul;33(4):745-752. doi: 10.3904/kjim.2017.030. Epub 2018 Mar 13. PubMed PMID:29529843; PubMed Central PMCID: PMC6030408. See more on PubMed
  • Barlo NP, van Moorsel CH, Ruven HJ, Zanen P, van den Bosch JM, Grutters JC.Surfactant protein-D predicts survival in patients with idiopathic pulmonaryfibrosis. Sarcoidosis Vasc Diffuse Lung Dis. 2009 Jul;26(2):155-61. PubMed PMID: 20560296. See more on PubMed
  • Bejvl I, Weseslindtner L, Strassl R, Jaksch P, Kundi M, Klepetko W,Puchhammer-Stöckl E. Analysis of plasma surfactant protein D levels in lungtransplant recipients. Transpl Infect Dis. 2013 Dec;15(6):645-51. doi:10.1111/tid.12132. Epub 2013 Sep 13. PubMed PMID: 24028302. See more on PubMed
  • Bønløkke JH, Riddervold IS, Grønborg TK, Skogstrand K, Hougaard DM, Barregard L, Sigsgaard T. Systemic effects of wood smoke in a short-term experimentalexposure study of atopic volunteers. J Occup Environ Med. 2014 Feb;56(2):177-83. doi: 10.1097/JOM.0000000000000067. PubMed PMID: 24451613; PubMed Central PMCID:PMC3921260. See more on PubMed
  • Bratcher PE, Gaggar A. Factors influencing the measurement of plasma/serumsurfactant protein D levels by ELISA. PLoS One. 2014 Nov 3;9(11):e111466. doi:10.1371/journal.pone.0111466. eCollection 2014. PubMed PMID: 25365324; PubMedCentral PMCID: PMC4218753. See more on PubMed
  • Bullone M, de Lagarde M, Vargas A, Lavoie JP. Serum Surfactant Protein D andHaptoglobin as Potential Biomarkers for Inflammatory Airway Disease in Horses. J Vet Intern Med. 2015 Nov-Dec;29(6):1707-11. doi: 10.1111/jvim.13602. Epub 2015Aug 19. PubMed PMID: 26289543; PubMed Central PMCID: PMC4895656. See more on PubMed
  • Choi S, Won YL, Kim D, Yi GY, Park JS, Kim EA. Subclinical interstitial lungdamage in workers exposed to indium compounds. Ann Occup Environ Med. 2013 Oct21;25(1):24. doi: 10.1186/2052-4374-25-24. PubMed PMID: 24472147; PubMed Central PMCID: PMC3923332. See more on PubMed
  • Chou CW, Chao HS, Lin FC, Tsai HC, Yuan WH, Chang SC. Clinical Usefulness ofHRCT in Assessing the Severity of Pneumocystis jirovecii Pneumonia: ACross-sectional Study. Medicine (Baltimore). 2015 Apr;94(16):e768. doi:10.1097/MD.0000000000000768. PubMed PMID: 25906111; PubMed Central PMCID:PMC4602686. See more on PubMed
  • Chou CW, Lin FC, Tsai HC, Chang SC. The impact of concomitant pulmonaryinfection on immune dysregulation in Pneumocystis jirovecii pneumonia. BMC PulmMed. 2014 Nov 19;14:182. doi: 10.1186/1471-2466-14-182. PubMed PMID: 25409888;PubMed Central PMCID: PMC4247696. See more on PubMed
  • Daneshzadeh Tabrizi R, Bernard A, Thommen AM, De Winter F, Oppliger A,Hilfiker S, Tschopp A, Hotz P. Surfactant protein-D and exposure to bioaerosolsin wastewater and garbage workers. Int Arch Occup Environ Health. 2010Dec;83(8):879-86. doi: 10.1007/s00420-010-0525-3. Epub 2010 Mar 11. PubMed PMID: 20221625. See more on PubMed
  • Delgado C, Krötzsch E, Jiménez-Alvarez LA, Ramírez-Martínez G, Márquez-García JE, Cruz-Lagunas A, Morán J, Hernández C, Sierra-Vargas P, Avila-Moreno F,Becerril C, Montaño M, Bañales-Méndez JL, Zúñiga J, Buendía-Roldán I. Serumsurfactant protein D (SP-D) is a prognostic marker of poor outcome in patientswith A/H1N1 virus infection. Lung. 2015 Feb;193(1):25-30. doi:10.1007/s00408-014-9669-3. Epub 2014 Dec 24. PubMed PMID: 25537934. See more on PubMed
  • Duda I, Grzybowska K, Jędrzejowska-Szypułka H, Lewin-Kowalik J. The sittingposition during neurosurgical procedures does not influence serum biomarkers ofpulmonary parenchymal injury. BMC Surg. 2012 Dec 5;12:24. doi:10.1186/1471-2482-12-24. PubMed PMID: 23217172; PubMed Central PMCID: PMC3521202. See more on PubMed
  • El-Deek SE, Makhlouf HA, Saleem TH, Mandour MA, Mohamed NA. Surfactant proteinD, soluble intercellular adhesion molecule-1 and high-sensitivity C-reactiveprotein as biomarkers of chronic obstructive pulmonary disease. Med Princ Pract. 2013;22(5):469-74. doi: 10.1159/000349934. Epub 2013 Jul 13. PubMed PMID:23860258; PubMed Central PMCID: PMC5586777. See more on PubMed
  • Engström G, Lindberg C, Gerhardsson de Verdier M, Nihlén U, Anderson M,Svartengren M, Forsman-Semb K. Blood biomarkers and measures of pulmonaryfunction--a study from the Swedish twin registry. Respir Med. 2012Sep;106(9):1250-7. doi: 10.1016/j.rmed.2012.05.004. Epub 2012 Jun 9. PubMed PMID:22687639. See more on PubMed
  • Erpenbeck VJ, Ziegert M, Cavalet-Blanco D, Martin C, Baelder R, Glaab T, BraunA, Steinhilber W, Luettig B, Uhlig S, Hoymann HG, Krug N, Hohlfeld JM. Surfactantprotein D inhibits early airway response in Aspergillus fumigatus-sensitizedmice. Clin Exp Allergy. 2006 Jul;36(7):930-40. PubMed PMID: 16839409. See more on PubMed
  • Fernández-Luna Á, Gallardo L, Plaza-Carmona M, García-Unanue J,Sánchez-Sánchez J, Felipe JL, Burillo P, Ara I. Respiratory function and changes in lung epithelium biomarkers after a short-training intervention in chlorinated vs. ozone indoor pools. PLoS One. 2013 Jul 12;8(7):e68447. doi:10.1371/journal.pone.0068447. Print 2013. PubMed PMID: 23874631; PubMed CentralPMCID: PMC3709909. See more on PubMed
  • Fernández-Real JM, Valdés S, Manco M, Chico B, Botas P, Campo A, CasamitjanaR, Delgado E, Salvador J, Fruhbeck G, Mingrone G, Ricart W. Surfactant protein d,a marker of lung innate immunity, is positively associated with insulinsensitivity. Diabetes Care. 2010 Apr;33(4):847-53. doi: 10.2337/dc09-0542. Epub2010 Jan 19. PubMed PMID: 20086254; PubMed Central PMCID: PMC2845040. See more on PubMed
  • Foreman MG, Kong X, DeMeo DL, Pillai SG, Hersh CP, Bakke P, Gulsvik A, LomasDA, Litonjua AA, Shapiro SD, Tal-Singer R, Silverman EK. Polymorphisms insurfactant protein-D are associated with chronic obstructive pulmonary disease.Am J Respir Cell Mol Biol. 2011 Mar;44(3):316-22. doi: 10.1165/rcmb.2009-0360OC. Epub 2010 May 6. PubMed PMID: 20448057; PubMed Central PMCID: PMC3095932. See more on PubMed
  • Gargiulo P, Banfi C, Ghilardi S, Magrì D, Giovannardi M, Bonomi A, Salvioni E,Battaia E, Filardi PP, Tremoli E, Agostoni P. Surfactant-derived proteins asmarkers of alveolar membrane damage in heart failure. PLoS One. 2014 Dec16;9(12):e115030. doi: 10.1371/journal.pone.0115030. eCollection 2014. PubMedPMID: 25514679; PubMed Central PMCID: PMC4267772. See more on PubMed
  • Gaunsbaek MQ, Kjeldsen AD, Svane-Knudsen V, Henriksen ML, Hansen S. Surfactantproteins A, B, C and D in the human nasal airway: associated with mucosal glands and ciliated epithelium but absent in fluid-phase secretions and mucus. ORL JOtorhinolaryngol Relat Spec. 2014;76(5):288-301. doi: 10.1159/000369143. Epub2014 Dec 10. PubMed PMID: 25500788. See more on PubMed
  • Gil HW, Hong JR, Park JH, Seo YS, Yang JO, Lee EY, Hong SY. Plasma surfactant D in patients following acute paraquat intoxication. Clin Toxicol (Phila). 2007Jun-Aug;45(5):463-7. PubMed PMID: 17503247. See more on PubMed
  • Glas J, Beynon V, Bachstein B, Steckenbiller J, Manolis V, Euba A,Müller-Myhsok B, Folwaczny M. Increased plasma concentration of surfactantprotein D in chronic periodontitis independent of SFTPD genotype: potential role as a biomarker. Tissue Antigens. 2008 Jul;72(1):21-8. doi:10.1111/j.1399-0039.2008.01056.x. Epub 2008 May 20. PubMed PMID: 18498293. See more on PubMed
  • Güzel A, Karadağ A, Okuyucu A, Alaçam H, Küçük Y. The evaluation of serumsurfactant protein D (SP-D) levels as a biomarker of lung injury in tuberculosis and different lung diseases. Clin Lab. 2014;60(7):1091-8. PubMed PMID: 25134376. See more on PubMed
  • Hant FN, Ludwicka-Bradley A, Wang HJ, Li N, Elashoff R, Tashkin DP, Silver RM;Scleroderma Lung Study Research Group. Surfactant protein D and KL-6 as serumbiomarkers of interstitial lung disease in patients with scleroderma. JRheumatol. 2009 Apr;36(4):773-80. doi: 10.3899/jrheum.080633. Epub 2009 Mar 13.PubMed PMID: 19286849. See more on PubMed
  • Heldal KK, Barregard L, Larsson P, Ellingsen DG. Pneumoproteins in sewageworkers exposed to sewage dust. Int Arch Occup Environ Health. 2013Jan;86(1):65-70. doi: 10.1007/s00420-012-0747-7. Epub 2012 Feb 17. PubMed PMID:22350277; PubMed Central PMCID: PMC3535374. See more on PubMed
  • Hill J, Heslop C, Man SF, Frohlich J, Connett JE, Anthonisen NR, Wise RA,Tashkin DP, Sin DD. Circulating surfactant protein-D and the risk ofcardiovascular morbidity and mortality. Eur Heart J. 2011 Aug;32(15):1918-25.doi: 10.1093/eurheartj/ehr124. Epub 2011 Jun 8. PubMed PMID: 21653561. See more on PubMed
  • Hodge S, Hodge G, Jersmann H, Matthews G, Ahern J, Holmes M, Reynolds PN.Azithromycin improves macrophage phagocytic function and expression of mannosereceptor in chronic obstructive pulmonary disease. Am J Respir Crit Care Med.2008 Jul 15;178(2):139-48. doi: 10.1164/rccm.200711-1666OC. Epub 2008 Apr 17.PubMed PMID: 18420960. See more on PubMed
  • Holz O, Tan L, Schaumann F, Müller M, Scholl D, Hidi R, McLeod A, Krug N,Hohlfeld JM. Inter- and intrasubject variability of the inflammatory response to segmental endotoxin challenge in healthy volunteers. Pulm Pharmacol Ther. 2015Dec;35:50-9. doi: 10.1016/j.pupt.2015.10.011. Epub 2015 Nov 10. PubMed PMID:26545873. See more on PubMed
  • Ju CR, Liu W, Chen RC. Serum surfactant protein D: biomarker of chronicobstructive pulmonary disease. Dis Markers. 2012;32(5):281-7. doi:10.3233/DMA-2011-0887. PubMed PMID: 22674408; PubMed Central PMCID: PMC3826904. See more on PubMed
  • Karottki DG, Spilak M, Frederiksen M, Jovanovic Andersen Z, Madsen AM, Ketzel M, Massling A, Gunnarsen L, Møller P, Loft S. Indoor and outdoor exposure toultrafine, fine and microbiologically derived particulate matter related tocardiovascular and respiratory effects in a panel of elderly urban citizens. Int J Environ Res Public Health. 2015 Feb 2;12(2):1667-86. doi:10.3390/ijerph120201667. PubMed PMID: 25648225; PubMed Central PMCID: PMC4344687. See more on PubMed
  • Kor DJ, Carter RE, Park PK, Festic E, Banner-Goodspeed VM, Hinds R, Talmor D, Gajic O, Ware LB, Gong MN; US Critical Illness and Injury Trials Group: LungInjury Prevention with Aspirin Study Group (USCIITG: LIPS-A). Effect of Aspirinon Development of ARDS in At-Risk Patients Presenting to the EmergencyDepartment: The LIPS-A Randomized Clinical Trial. JAMA. 2016 Jun14;315(22):2406-14. doi: 10.1001/jama.2016.6330. Erratum in: JAMA. 2016 Sep13;316(10):1116. PubMed PMID: 27179988; PubMed Central PMCID: PMC5450939. See more on PubMed
  • Kucejko W, Chyczewska E, Naumnik W, Ossolińska M. Concentration of surfactant protein D, Clara cell protein CC-16 and IL-10 in bronchoalveolar lavage (BAL) in patients with sarcoidosis, hypersensivity pneumonitis and idiopathic pulmonaryfibrosis. Folia Histochem Cytobiol. 2009;47(2):225-30. doi:10.2478/v10042-009-0028-9. PubMed PMID: 19995708. See more on PubMed
  • Kunisaki KM, Quick H, Baker JV. HIV antiretroviral therapy reduces circulatingsurfactant protein-D levels. HIV Med. 2011 Oct;12(9):580-1. doi:10.1111/j.1468-1293.2011.00920.x. PubMed PMID: 21951596; PubMed Central PMCID:PMC3629819. See more on PubMed
  • Liu HH, Chen CY, Chen GI, Lee LH, Chen HL. Relationship between indiumexposure and oxidative damage in workers in indium tin oxide production plants.Int Arch Occup Environ Health. 2012 May;85(4):447-53. doi:10.1007/s00420-011-0688-6. Epub 2011 Aug 11. PubMed PMID: 21833746. See more on PubMed
  • Liu W, Ju CR, Chen RC, Liu ZG. Role of serum and induced sputum surfactantprotein D in predicting the response to treatment in chronic obstructivepulmonary disease. Exp Ther Med. 2014 Oct;8(4):1313-1317. Epub 2014 Jul 29.PubMed PMID: 25187846; PubMed Central PMCID: PMC4151639. See more on PubMed
  • Lomas DA, Silverman EK, Edwards LD, Locantore NW, Miller BE, Horstman DH,Tal-Singer R; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints study investigators. Serum surfactant protein D is steroid sensitiveand associated with exacerbations of COPD. Eur Respir J. 2009 Jul;34(1):95-102.doi: 10.1183/09031936.00156508. Epub 2009 Jan 22. PubMed PMID: 19164344. See more on PubMed
  • Miller J, Edwards LD, Agustí A, Bakke P, Calverley PM, Celli B, Coxson HO,Crim C, Lomas DA, Miller BE, Rennard S, Silverman EK, Tal-Singer R, Vestbo J,Wouters E, Yates JC, Macnee W; Evaluation of COPD Longitudinally to IdentifyPredictive Surrogate Endpoints (ECLIPSE) Investigators. Comorbidity, systemicinflammation and outcomes in the ECLIPSE cohort. Respir Med. 2013Sep;107(9):1376-84. doi: 10.1016/j.rmed.2013.05.001. Epub 2013 Jun 19. PubMedPMID: 23791463. See more on PubMed
  • Nickmilder M, Carbonnelle S, Bernard A. House cleaning with chlorine bleachand the risks of allergic and respiratory diseases in children. Pediatr AllergyImmunol. 2007 Feb;18(1):27-35. PubMed PMID: 17295796. See more on PubMed
  • Ozyurek BA, Ulasli SS, Bozbas SS, Bayraktar N, Akcay S. Value of serum andinduced sputum surfactant protein-D in chronic obstructive pulmonary disease.Multidiscip Respir Med. 2013 Jun 1;8(1):36. doi: 10.1186/2049-6958-8-36. PubMedPMID: 23725346; PubMed Central PMCID: PMC3670831. See more on PubMed
  • Piperis M, Provatopoulou X, Sagkriotis A, Kalogera E, Ampatzoglou E, Zografos GC, Athanasiou E, Gounaris A. Effect of breast cancer adjuvant therapies onpotential biomarkers of pulmonary inflammation. Anticancer Res. 2012Nov;32(11):4993-5002. PubMed PMID: 23155270. See more on PubMed
  • Proudfoot A, Bayliffe A, O'Kane CM, Wright T, Serone A, Bareille PJ, Brown V, Hamid UI, Chen Y, Wilson R, Cordy J, Morley P, de Wildt R, Elborn S, Hind M,Chilvers ER, Griffiths M, Summers C, McAuley DF. Novel anti-tumour necrosisfactor receptor-1 (TNFR1) domain antibody prevents pulmonary inflammation inexperimental acute lung injury. Thorax. 2018 Aug;73(8):723-730. doi:10.1136/thoraxjnl-2017-210305. Epub 2018 Jan 29. PubMed PMID: 29382797; PubMedCentral PMCID: PMC6204954. See more on PubMed
  • Richard EA, Pitel PH, Christmann U, Lekeux P, Fortier G, Pronost S. Serumconcentration of surfactant protein D in horses with lower airway inflammation.Equine Vet J. 2012 May;44(3):277-81. doi: 10.1111/j.2042-3306.2011.00421.x. Epub 2011 Jun 23. PubMed PMID: 21696440. See more on PubMed
  • Sayiner A, Hague C, Ajlan A, Leipsic J, Wierenga L, Krowchuk NM, Ceylan N,Sayiner A, Sin DD, Coxson HO. Bronchiolitis in young female smokers. Respir Med. 2013 May;107(5):732-8. doi: 10.1016/j.rmed.2012.12.023. Epub 2013 Jan 23. PubMed PMID: 23352225. See more on PubMed
  • Schnapp LM, Donohoe S, Chen J, Sunde DA, Kelly PM, Ruzinski J, Martin T,Goodlett DR. Mining the acute respiratory distress syndrome proteome:identification of the insulin-like growth factor (IGF)/IGF-binding protein-3pathway in acute lung injury. Am J Pathol. 2006 Jul;169(1):86-95. PubMed PMID:16816363; PubMed Central PMCID: PMC1698774. See more on PubMed
  • Shakoori TA, Sin DD, Ghafoor F, Bashir S, Bokhari SN. Serum surfactant proteinD during acute exacerbations of chronic obstructive pulmonary disease. DisMarkers. 2009;27(6):287-94. doi: 10.3233/DMA-2009-0674. PubMed PMID: 20075511;PubMed Central PMCID: PMC3834666. See more on PubMed
  • Shiels MS, Chaturvedi AK, Katki HA, Gochuico BR, Caporaso NE, Engels EA.Circulating markers of interstitial lung disease and subsequent risk of lungcancer. Cancer Epidemiol Biomarkers Prev. 2011 Oct;20(10):2262-72. doi:10.1158/1055-9965.EPI-11-0326. Epub 2011 Aug 9. PubMed PMID: 21828236; PubMedCentral PMCID: PMC3189337. See more on PubMed
  • Sims MW, Tal-Singer RM, Kierstein S, Musani AI, Beers MF, Panettieri RA,Haczku A. Chronic obstructive pulmonary disease and inhaled steroids altersurfactant protein D (SP-D) levels: a cross-sectional study. Respir Res. 2008 Jan28;9:13. doi: 10.1186/1465-9921-9-13. PubMed PMID: 18226251; PubMed CentralPMCID: PMC2249580. See more on PubMed
  • Sin DD, Leung R, Gan WQ, Man SP. Circulating surfactant protein D as apotential lung-specific biomarker of health outcomes in COPD: a pilot study. BMC Pulm Med. 2007 Oct 8;7:13. PubMed PMID: 17922919; PubMed Central PMCID:PMC2096624. See more on PubMed
  • Sin DD, Man SF, Marciniuk DD, Ford G, FitzGerald M, Wong E, York E, Mainra RR,Ramesh W, Melenka LS, Wilde E, Cowie RL, Williams D, Gan WQ, Rousseau R; ABC(Advair, Biomarkers in COPD) Investigators. The effects of fluticasone with orwithout salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008 Jun 1;177(11):1207-14. doi:10.1164/rccm.200709-1356OC. Epub 2008 Feb 28. PubMed PMID: 18310480. See more on PubMed
  • Sin DD, Man SFP, McWilliams A, Lam S. Surfactant protein D and bronchialdysplasia in smokers at high risk of lung cancer. Chest. 2008 Sep;134(3):582-588.doi: 10.1378/chest.08-0600. PubMed PMID: 18779194. See more on PubMed
  • Sorensen GL, Husby S, Holmskov U. Surfactant protein A and surfactant protein D variation in pulmonary disease. Immunobiology. 2007;212(4-5):381-416. Epub 2007Feb 23. Review. PubMed PMID: 17544823. See more on PubMed
  • Stapleton RD, Dixon AE, Parsons PE, Ware LB, Suratt BT; NHLBI AcuteRespiratory Distress Syndrome Network. The association between BMI and plasmacytokine levels in patients with acute lung injury. Chest. 2010Sep;138(3):568-77. doi: 10.1378/chest.10-0014. Epub 2010 Apr 30. PubMed PMID:20435656; PubMed Central PMCID: PMC2940070. See more on PubMed
  • Stapleton RD, Martin TR, Weiss NS, Crowley JJ, Gundel SJ, Nathens AB, AkhtarSR, Ruzinski JT, Caldwell E, Curtis JR, Heyland DK, Watkins TR, Parsons PE,Martin JM, Wurfel MM, Hallstrand TS, Sims KA, Neff MJ. A phase II randomizedplacebo-controlled trial of omega-3 fatty acids for the treatment of acute lunginjury. Crit Care Med. 2011 Jul;39(7):1655-62. doi: 10.1097/CCM.0b013e318218669d.PubMed PMID: 21423000; PubMed Central PMCID: PMC3125670. See more on PubMed
  • Sun W, Kechris K, Jacobson S, Drummond MB, Hawkins GA, Yang J, Chen TH,Quibrera PM, Anderson W, Barr RG, Basta PV, Bleecker ER, Beaty T, Casaburi R,Castaldi P, Cho MH, Comellas A, Crapo JD, Criner G, Demeo D, Christenson SA,Couper DJ, Curtis JL, Doerschuk CM, Freeman CM, Gouskova NA, Han MK, Hanania NA, Hansel NN, Hersh CP, Hoffman EA, Kaner RJ, Kanner RE, Kleerup EC, Lutz S,Martinez FJ, Meyers DA, Peters SP, Regan EA, Rennard SI, Scholand MB, SilvermanEK, Woodruff PG, O'Neal WK, Bowler RP; SPIROMICS Research Group; COPDGeneInvestigators. Common Genetic Polymorphisms Influence Blood BiomarkerMeasurements in COPD. PLoS Genet. 2016 Aug 17;12(8):e1006011. doi:10.1371/journal.pgen.1006011. eCollection 2016 Aug. PubMed PMID: 27532455; PubMedCentral PMCID: PMC4988780. See more on PubMed
  • Suzuki T, Sakagami T, Rubin BK, Nogee LM, Wood RE, Zimmerman SL, Smolarek T,Dishop MK, Wert SE, Whitsett JA, Grabowski G, Carey BC, Stevens C, van der LooJC, Trapnell BC. Familial pulmonary alveolar proteinosis caused by mutations inCSF2RA. J Exp Med. 2008 Nov 24;205(12):2703-10. doi: 10.1084/jem.20080990. Epub2008 Oct 27. PubMed PMID: 18955570; PubMed Central PMCID: PMC2585845. See more on PubMed
  • Ulvestad B, Randem BG, Andersson L, Ellingsen DG, Barregard L. Clara cellprotein as a biomarker for lung epithelial injury in asphalt workers. J OccupEnviron Med. 2007 Oct;49(10):1073-8. PubMed PMID: 18000412. See more on PubMed
  • Um SJ, Lam S, Coxson H, Man SF, Sin DD. Budesonide/formoterol enhances theexpression of pro Surfactant Protein-B in lungs of COPD patients. PLoS One. 2013 Dec 26;8(12):e83881. doi: 10.1371/journal.pone.0083881. eCollection 2013. PubMed PMID: 24386300; PubMed Central PMCID: PMC3873417. See more on PubMed
  • Vaes B, Pasquet A, Wallemacq P, Rezzoug N, Mekouar H, Olivier PA, Legrand D,Matheï C, Van Pottelbergh G, Degryse J. The BELFRAIL (BFC80+) study: apopulation-based prospective cohort study of the very elderly in Belgium. BMCGeriatr. 2010 Jun 17;10:39. doi: 10.1186/1471-2318-10-39. PubMed PMID: 20565795; PubMed Central PMCID: PMC2906485. See more on PubMed
  • Vizcaya D, Mirabelli MC, Orriols R, Antó JM, Barreiro E, Burgos F, Arjona L,Gomez F, Zock JP. Functional and biological characteristics of asthma in cleaningworkers. Respir Med. 2013 May;107(5):673-83. doi: 10.1016/j.rmed.2013.01.011.Epub 2013 Feb 20. PubMed PMID: 23433770. See more on PubMed
  • Wang SX, Liu P, Wei MT, Chen L, Guo Y, Wang RY, Tu ZG, Liang XC. Roles ofserum clara cell protein 16 and surfactant protein-D in the early diagnosis andprogression of silicosis. J Occup Environ Med. 2007 Aug;49(8):834-9. PubMed PMID:17693780. See more on PubMed
  • Watkins TR, Rubenfeld GD, Martin TR, Nester TA, Caldwell E, Billgren J,Ruzinski J, Nathens AB. Effects of leukoreduced blood on acute lung injury after trauma: a randomized controlled trial. Crit Care Med. 2008 May;36(5):1493-9. doi:10.1097/CCM.0b013e318170a9ce. PubMed PMID: 18434890. See more on PubMed
  • Winkler C, Atochina-Vasserman EN, Holz O, Beers MF, Erpenbeck VJ, Krug N,Roepcke S, Lauer G, Elmlinger M, Hohlfeld JM. Comprehensive characterisation ofpulmonary and serum surfactant protein D in COPD. Respir Res. 2011 Mar 11;12:29. doi: 10.1186/1465-9921-12-29. PubMed PMID: 21396106; PubMed Central PMCID:PMC3061904. See more on PubMed
  • Winkler C, Bahlmann O, Viereck J, Knudsen L, Wedekind D, Hoymann HG, Madsen J,Thum T, Hohlfeld JM, Ochs M. Impact of a Met(11)Thr single nucleotidepolymorphism of surfactant protein D on allergic airway inflammation in a murine asthma model. Exp Lung Res. 2014 Apr;40(4):154-63. doi:10.3109/01902148.2014.891062. PubMed PMID: 24712849. See more on PubMed
  • Wutzler S, Lehnert T, Laurer H, Lehnert M, Becker M, Henrich D, Vogl T, Marzi I. Circulating levels of Clara cell protein 16 but not surfactant protein Didentify and quantify lung damage in patients with multiple injuries. J Trauma.2011 Aug;71(2):E31-6. doi: 10.1097/TA.0b013e3181f6f0b4. PubMed PMID: 21045740. See more on PubMed
  • Tekerek NU, Akyildiz BN, Ercal BD, Muhtaroglu S. New Biomarkers to DiagnoseVentilator Associated Pneumonia: Pentraxin 3 and Surfactant Protein D. Indian JPediatr. 2018 Jun;85(6):426-432. doi: 10.1007/s12098-018-2607-2. Epub 2018 Feb 2.PubMed PMID: 29396775. See more on PubMed
  • McNeil JB, Shaver CM, Kerchberger VE, Russell DW, Grove BS, Warren MA,Wickersham NE, Ware LB, McDonald WH, Bastarache JA. Novel Method for Noninvasive Sampling of the Distal Airspace in Acute Respiratory Distress Syndrome. Am JRespir Crit Care Med. 2018 Apr 15;197(8):1027-1035. doi:10.1164/rccm.201707-1474OC. PubMed PMID: 29253353; PubMed Central PMCID:PMC5909163. See more on PubMed
  • Papaioannou AI, Konstantelou E, Papaporfyriou A, Bartziokas K, Spathis A,Bakakos P, Loukides S, Koulouris N, Papiris S, Kostikas K. Serum SurfactantProtein Levels in Patients Admitted to the Hospital with Acute COPD Exacerbation.Lung. 2018 Apr;196(2):201-205. doi: 10.1007/s00408-018-0099-5. Epub 2018 Feb 14. PubMed PMID: 29445934. See more on PubMed
  • Kirkhus NE, Ulvestad B, Barregard L, Skare Ø, Olsen R, Thomassen Y, Ellingsen DG. Pneumoproteins in Offshore Drill Floor Workers. Int J Environ Res PublicHealth. 2019 Jan 23;16(3). pii: E300. doi: 10.3390/ijerph16030300. PubMed PMID:30678045; PubMed Central PMCID: PMC6388385. See more on PubMed
  • Chaumont M, van de Borne P, Bernard A, Van Muylem A, Deprez G, Ullmo J,Starczewska E, Briki R, de Hemptinne Q, Zaher W, Debbas N. Fourth generatione-cigarette vaping induces transient lung inflammation and gas exchangedisturbances: results from two randomized clinical trials. Am J Physiol Lung CellMol Physiol. 2019 May 1;316(5):L705-L719. doi: 10.1152/ajplung.00492.2018. Epub2019 Feb 6. PubMed PMID: 30724099; PubMed Central PMCID: PMC6589591. See more on PubMed
Summary References (9)

References to Surfactant Protein D

  • Crouch EC. Surfactant protein-D and pulmonary host defense. Respir Res. 2000;1 (2):93-108
  • Greene KE, Wright JR, Steinberg KP, Ruzinski JT, Caldwell E, Wong WB, Hull W, Whitsett JA, Akino T, Kuroki Y, Nagae H, Hudson LD, Martin TR. Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS. Am J Respir Crit Care Med. 1999 Dec;160 (6):1843-50
  • Honda Y, Kuroki Y, Matsuura E, Nagae H, Takahashi H, Akino T, Abe S. Pulmonary surfactant protein D in sera and bronchoalveolar lavage fluids. Am J Respir Crit Care Med. 1995 Dec;152 (6 Pt 1):1860-6
  • Inoue T, Matsuura E, Nagata A, Ogasawara Y, Hattori A, Kuroki Y, Fujimoto S, Akino T. Enzyme-linked immunosorbent assay for human pulmonary surfactant protein D. J Immunol Methods. 1994 Aug 1;173 (2):157-64
  • Nagae H, Takahashi H, Kuroki Y, Honda Y, Nagata A, Ogasawara Y, Abe S, Akino T. Enzyme-linked immunosorbent assay using F(ab')2 fragment for the detection of human pulmonary surfactant protein D in sera. Clin Chim Acta. 1997 Oct 31;266 (2):157-71
  • Ohnishi H, Yokoyama A, Kondo K, Hamada H, Abe M, Nishimura K, Hiwada K, Kohno N. Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases. Am J Respir Crit Care Med. 2002 Feb 1;165 (3):378-81
  • Takahashi H, Fujishima T, Koba H, Murakami S, Kurokawa K, Shibuya Y, Shiratori M, Kuroki Y, Abe S. Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent. Am J Respir Crit Care Med. 2000 Sep;162 (3 Pt 1):1109-14
  • Takahashi H, Kuroki Y, Tanaka H, Saito T, Kurokawa K, Chiba H, Sagawa A, Nagae H, Abe S. Serum levels of surfactant proteins A and D are useful biomarkers for interstitial lung disease in patients with progressive systemic sclerosis. Am J Respir Crit Care Med. 2000 Jul;162 (1):258-63
  • Ciftci F, Sen E, Arkan G, Acar D, Saryal S. The relation between serum surfactant protein-d level and chronic obstructive pulmonary disease severity.Biomedical Research (2018) Volume 29, Issue 7
Related Products Docs